RenaissanceRe Holdings Ltd. Overview
Three-year headcount trend. RenaissanceRe's headcount expanded materially after the November 2023 acquisition of Validus Re, which added underwriting, claims and ILS (AlphaCat) staff. A third-party profile cites approximately 1,040 employees for FY2025.
Aggregator figure for FY2025: ~1,040.
RenaissanceRe is one of the world's leading independent property-catastrophe reinsurers and, following its 2023 acquisition of Validus Re from AIG, a top-tier global property, casualty and specialty reinsurer writing approximately USD 11.7 billion of gross premiums annually (FY2025). Its stated mission — "matching desirable risk with efficient capital" — is executed through three "drivers of profit": underwriting income, fee income from managing third-party capital (DaVinciRe, Medici, Vermeer, Fontana, Upsilon, AlphaCat and others), and net investment income from a roughly USD 30+ billion investment portfolio. The firm's competitive edge rests on proprietary catastrophe modelling (REMS©-lineage analytics), a long-tenured leadership team, preferential "lead" access to cedents through brokers, and the ability to flex between balance-sheet and partner capital through the cycle. Its shares trade at a premium to book value on the strength of three consecutive years of 25%+ tangible book value growth, but the company now faces softening property-catastrophe pricing and persistent underwriting losses in casualty and specialty.
Company's own description
RenaissanceRe describes itself as "a global provider of reinsurance and insurance that specializes in matching desirable risk with efficient capital," providing "property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries." It states that it was established in 1993, is headquartered in Bermuda and has offices across North America, Europe and the Asia-Pacific region (Source: standard "About RenaissanceRe" boilerplate, Q1 and Q2 2026 earnings releases).
What the company does
RenaissanceRe assumes risk from primary insurance companies (cedents), from other reinsurers (retrocession) and, to a lesser extent, directly from insureds via delegated authority and specialty insurance channels. It does so in two reportable segments:
Property: catastrophe excess-of-loss reinsurance (the company's historic core: protection for insurers against hurricanes, earthquakes, wildfires, floods, severe convective storms and other natural perils), plus "other property" (proportional/quota share property, risk excess-of-loss, and property business written on a delegated basis).
Casualty and Specialty: general casualty (auto liability, casualty clash, employers' liability, umbrella/excess casualty, workers' compensation, general liability), professional liability (D&O, E&O, medical malpractice, cyber), credit (mortgage, surety, trade credit, political risk), and other specialty lines (marine, energy, aviation, terrorism, accident & health, agriculture and others) [V for general casualty definition, Q1–Q3 2025 releases].
Business and revenue model
| Driver | What it is | FY2025 figure | Source |
|---|---|---|---|
| Underwriting income | Net premiums earned less claims, acquisition and operational expenses | USD 1,270.0M | 10-K FY2025 [V] |
| Fee income | Management and performance fees earned from third-party capital vehicles | ~USD 329M | Q4 2025 earnings materials [V] |
| Net investment income | Coupon/dividend income from invested assets (including float) | USD 1,703.5M | 10-K FY2025 [V] |
For a reinsurer, "revenue" consists of three streams, which management explicitly frames as the "three drivers of profit":
Net income additionally includes net realized and unrealized investment gains/losses, which are excluded from the company's "operating income" non-GAAP measure. In FY2025 net income available to common shareholders was USD 2,647.0M versus operating income available to common shareholders of USD 1,859.7M, the difference driven principally by investment gains [V].
Revenue mix characterization (template categories): the business is predominantly a risk-transfer (premium) model with a growing asset-management (fee) component through RenaissanceRe Capital Partners. There is no product, subscription or licensing revenue in the industrial sense. Premiums are typically annual contracts concentrated at the 1 January, 1 April, 1 June and 1 July renewal dates.
Value chain position
RenaissanceRe sits at the wholesale layer of the risk-transfer value chain: primary insurers write policies to households and businesses; reinsurers like RenaissanceRe absorb the volatile tail of those portfolios; capital-markets investors (pension funds, sovereign funds, ILS funds) provide additional capacity either directly through catastrophe bonds or via reinsurer-sponsored vehicles. RenaissanceRe straddles the last two layers — it is both a rated balance-sheet reinsurer and a manager of third-party capital, enabling it to capture fees on risk that it chooses not to retain.
Customer types and distribution
Customers are primary insurers (national, regional, mutual and state-backed entities, including Florida domestic insurers and U.S. state residual-market facilities), other reinsurers, Lloyd's syndicates, and selected corporates/government entities. Business is sourced "principally through intermediaries"; the company's risk factors highlight reliance on a small number of large brokers (Source: forward-looking statements in 2026 earnings releases [V]).
End-markets served
Global property-catastrophe reinsurance (U.S. peak perils dominant, with significant Japan, Europe, Australia/NZ and Caribbean exposure), global casualty reinsurance (predominantly U.S. liability), specialty reinsurance (credit/mortgage, marine and energy, cyber, aviation), and insurance-linked securities/third-party capital management.
Independent characterization
RenaissanceRe is best understood as a catastrophe-risk specialist that has diversified into a scale reinsurer. The Property segment generated USD 1,533.3M of underwriting income in FY2025 at a 61.4% combined ratio, while Casualty and Specialty generated an underwriting loss of USD 263.3M at a 104.4% combined ratio [V]. In other words, more than 100% of group underwriting profit comes from the property book, while casualty and specialty functions primarily as a float-generating, capital-efficient (diversifying) business whose economic contribution depends heavily on investment income on its long-tail reserves. This mix is a deliberate strategic choice — casualty float diversifies capital requirements against catastrophe peaks — but the persistently above-100% casualty combined ratio is the central analytical debate around the stock.
Strategy
Stated corporate strategy (themes)
Mission: "matching desirable risk with efficient capital" [V].
Three drivers of profit: underwriting income, fee income, net investment income — repeated in every 2025–2026 earnings release and call [V].
Primary performance metric: growth in tangible book value per share plus change in accumulated dividends; management highlighted a third consecutive year of 25%+ TBVPS growth in 2025 [V, secondary].
Consistency: "Our strategy does not change from quarter to quarter" (CEO, Q2 2026 call [V]).
Underwriting discipline in a changing market: management characterized the mid-2026 environment as "changing" rather than "soft," citing broadly intact rate adequacy across most lines [V].
Gross-to-net strategy: retaining more profitable property risk (FY2025 property ceded premiums −9.3%) while buying more quota-share retro on casualty (FY2025 casualty ceded +22.7%) [V].
Capital management: returning excess capital through buybacks when the stock trades at valuations accretive to TBVPS [V].
Strategic initiatives (last 24 months)
| Initiative | Date | Description | Status |
|---|---|---|---|
| Validus integration | Nov 2023 – 2025 | Integration of Validus Re, AlphaCat and Talbot renewal rights; purchase-accounting adjustments declining (cited in Q2 2026 expense-ratio improvement) | Substantially complete [V for declining PAA] |
| Capital Partners expansion | 2023–2026 | Fee income nearly tripled from ~USD 120M (2022) to ~USD 329M (2025) | Ongoing [V] |
| Casualty de-risking | 2025–2026 | Increased quota-share retrocession; reduced general casualty and professional liability writings; caution on social inflation | Ongoing [V] |
| Bermuda corporate income tax adaptation | 2025–2026 | Bermuda tax credits recorded in Q2 2026 reduced the expense ratio by contributing to a 1.9-point improvement | [V] |
| Debt refinancing | 2,025 | Net issuance of ~USD 889M of debt and repayment of USD 450M (incl. USD 150M Medici revolver) | [V] |
| Executive succession | May 2026 | CFO and CPO succession; board chair change | [V] |
| Secured letter of credit facility extension | Dec 2025 | Extension of secured LOC facility | [V, CNN news feed headline] |
| Automatic mixed securities shelf | 2,026 | New automatic shelf registration filed | [V, StockAnalysis headline] |
Medium-term targets / guidance
RenaissanceRe does not issue formal earnings guidance [V, secondary]. It does provide directional commentary on calls, e.g., the Q4 2025 call indicated a full-year operating expense ratio of ~5–5.5%, other property net premiums earned of ~USD 360M per quarter, and a phase-in of Bermuda tax benefits with full benefit by 2027 (Source: Fintool summary of Q4 2025 call [V, secondary]). There are no published multi-year ROE or growth targets.
Products & Services
RenaissanceRe does not sell branded consumer products; its "portfolio" consists of reinsurance classes, insurance programs and third-party capital vehicles. Pricing is contract-specific and not publicly disclosed; the general pricing model for each class is described below.
Property segment
| Offering | Description | Target customer | Pricing model | Status |
|---|---|---|---|---|
| Catastrophe excess-of-loss reinsurance | Per-occurrence and aggregate protection against natural perils (U.S. hurricane, earthquake, wildfire, severe convective storm; Japan, Europe, Australasia, Caribbean perils) | National, regional and Florida-domestic primary insurers; state entities | Rate-on-line priced per layer; reinstatement premiums | Core since 1993 [V] |
| Catastrophe retrocession | Reinsurance of other reinsurers' catastrophe portfolios | Global reinsurers, Lloyd's syndicates | Rate-on-line | Core [M] |
| Other property — proportional/quota share | Share of cedents' property portfolios (including catastrophe-exposed) | Primary insurers, MGAs | Ceding commission plus share of premium | Expanded via Validus [M] |
| Other property — per-risk excess of loss | Protection against large individual commercial property losses | Commercial property insurers | Layer pricing | [M] |
| Delegated-authority property | Property business written via MGAs/coverholders | Specialty program carriers | Commission-based | [M] |
Casualty and Specialty segment
| Class | Lines included | Typical structure | Status |
|---|---|---|---|
| General casualty | Automobile liability, casualty clash, employers' liability, umbrella/excess casualty, workers' compensation, general liability | Mostly proportional (quota share) | [V] (definition per earnings supplements) |
| Professional liability | D&O, E&O, medical malpractice, cyber liability, transactional/other professional lines | Proportional and excess of loss | [V] class name; line composition [M] |
| Credit | Mortgage reinsurance (incl. U.S. GSE credit risk transfer), surety, trade credit, political risk | Quota share and XoL | Class name [V]; Q4 2025 growth in credit class [V] |
| Other specialty | Marine, energy, aviation and space, terrorism, accident & health, agriculture, and miscellaneous specialty | Mixed | [M] |
Management notes that proportional business — the majority of the Casualty and Specialty segment — typically carries a higher expense ratio and more frequent attritional losses but lower expected severity than excess-of-loss business (Source: 10-K FY2025 [V]).
Capital Partners (third-party capital vehicles) — "fee income" products
| Vehicle | Type | Partners / investors | Launch | Status |
|---|---|---|---|---|
| DaVinciRe Holdings / DaVinci Reinsurance Ltd. | Rated property-cat reinsurer; joint venture with third-party equity | Institutional investors | 2001 [M] | Flagship; consolidated |
| Top Layer Reinsurance Ltd. | High-layer U.S. property-cat JV | State Farm | 1999 [M] | Active (status not re-verified) |
| Medici | Open-ended catastrophe bond fund | Institutional investors | 2017 [M] | Active; Medici revolving credit facility repaid USD 150M in 2025 [V] |
| Vermeer Reinsurance Ltd. | Sidecar-style vehicle for low-frequency U.S. property cat | PGGM (Dutch pension manager) | 2021 [M] | Active |
| Upsilon RFO / Upsilon Diversified | Collateralized aggregate/retro vehicle | Institutional investors | ~2014 [M] | Active |
| Fontana | Casualty-focused third-party capital vehicle | Institutional investors | 2023 [M] | Active |
| AlphaCat (acquired with Validus) | ILS fund manager | Institutional investors | Acquired Nov 2023 [M] | Integrated into Capital Partners |
| Langhorne (with PGGM / reinsurance of life & annuity) | Former life & annuity vehicle | — | — | — |
Fee income growth has been a core strategic achievement: capital partner fees nearly tripled from ~USD 120M in 2022 to just over USD 300M on a trailing four-quarter basis by Q3 2025, and reached ~USD 329M for FY2025 (Source: Q3 2025 earnings call transcript; Q4 2025 materials [V]). Fee income was USD 94.1M in Q1 2026 and USD 83.0M in Q2 2026, with "strong contributions from management and performance fees" [V].
Analytics and services (non-revenue capabilities)
Proprietary catastrophe modelling: the REMS© platform lineage, built from the company's founding, used to price and aggregate catastrophe risk [M].
Portfolio optimization ("gross-to-net" strategy): managed by the Chief Portfolio Officer function (Ross Curtis, retiring 31 Dec 2026; responsibilities passing to Group CUO David Marra) [V].
Financial Narrative
Adaptation note. Gross profit, EBITDA, capex, free cash flow (as conventionally defined), working capital, current ratio, ROIC, asset turnover and cash conversion cycle are not reported by, or meaningful for, a reinsurer. They are replaced below with combined ratio, underwriting income, net investment income, operating income, book value and ROACE.
Income statement and underwriting
Sources: FY2024 and FY2025 from 10-K FY2025 [V]; GPW 2021–2022 [M] (2022 GPW USD 9.2B corroborated by the June 2023 anniversary release [V]); 2021–2023 net income and EPS: basic EPS per XBRL aggregator of 10-K data [V], net income [M]; FY2023 diluted EPS approximate [M]. FY2024 operating income ~USD 2.2B per Fintool summary; FY2024 operating EPS derived (USD 39.10 is down 9% YoY per Zacks/Nasdaq, implying ~USD 42.97). Fee income 2022 per Q3 2025 earnings call ("~USD 120M in 2022").
Sources: 10-K FY2025 [V]; ROACE 2025 ~25.96% per AlphaQuery; operating ROACE per Fintool Q4 2025 summary [V, secondary].
Premium CAGR. GPW grew from USD 7,833.9M (FY2021) to USD 11,738.4M (FY2025), a four-year CAGR of approximately 10.6%, though almost all of this is attributable to the Validus acquisition (inorganic) and the hard-market rate increases of 2023–2024. FY2025 GPW was flat (+0.0%) and 2026 year-to-date GPW is declining.
Balance sheet
Sources: Total assets, goodwill/intangibles, equity attributable: XBRL aggregator of 10-K filings (edgar.tools) [V]; FY2024–FY2025 debt and common equity: 10-K FY2025 capital resources table [V]; earlier debt: StockAnalysis aggregation of 10-Ks [V, secondary; includes small short-term borrowings]; total equity incl. NCI: StockAnalysis [V, secondary]; BVPS 2024–2025 and TBVPS [V]; BVPS 2021–2023 [M].
Cash and investments. Total cash and short-term investments plus fixed maturities were approximately USD 31.4 billion at 31 Dec 2025 and USD 30.4 billion at 30 Jun 2026 (Weiss Ratings aggregation of 10-Q/10-K [V, secondary]). The investment portfolio is predominantly high-grade fixed income; a gold position contributed to 2025 investment gains (referenced in Fintool's Q4 2025 summary) [V, secondary].
Net debt. For an insurer with ~USD 30B of liquid investments supporting reserves, net debt/EBITDA is not meaningful. Debt-to-capital (senior notes ÷ [senior notes + total RNR shareholders' equity]) was approximately 16.7% at FY2025 (2,329 ÷ [2,329 + 11,609]) versus 15.1% at FY2024 — computed from 10-K figures. Including preference shares as hybrid capital, leverage was ~22%.
Cash flow and capital return
Sources: OCF per AlphaQuery [V, secondary]; FY2025 buybacks ~USD 1.6B (Q4 2025 USD 650M) per Fintool summary of Q4 2025 call [V, secondary]; debt flows per edgar.tools XBRL extraction [V]. Note that the 10-K liquidity section separately references "common share repurchases of USD 666.9 million" in a holding-company context, which likely reflects a sub-period or parent-only figure; the discrepancy with the ~USD 1.6B consolidated figure is flagged and should be reconciled against the 10-K cash flow statement.
2026 capital return to date. Q1 2026 buybacks USD 352.5M; Q2 2026 USD 350.0M; 1–20 July 2026 a further USD 82.9M — total ~USD 785M through 20 July 2026 [V]. Between 1 April and 24 April 2026 the company repurchased 340.5 thousand shares at an average USD 307.89 (Source: 10-Q Q1 2026 subsequent events [V]).
Ratios
Computed from 10-K figures; ROACE per AlphaQuery.
Interim 2026 financial summary
Sources: Q1 and Q2 2026 earnings releases and 10-Qs [V]. Q1 2026 operating EPS USD 13.75 per Earnings consensus coverage [V, secondary].
Commentary on trends, inflections and drivers
2021–2022: the loss years. RenaissanceRe produced small and then large net losses to common in 2021 (−USD 73M) and 2022 (−USD 1.1B). 2021 was dominated by Hurricane Ida, Winter Storm Uri and the July European floods (Q3 2021 alone ~USD 725M of catastrophe impact [V]). 2022 combined Hurricane Ian (~USD 540M of a ~USD 650M Q3 catastrophe hit [V]) with a sharp rise in interest rates that produced large unrealized losses on the bond portfolio. BVPS fell from ~USD 137 to ~USD 105 [M].
2023: inflection. The January 2023 renewal was the hardest property-cat market in a generation; RenaissanceRe raised rates and attachment points, then acquired Validus Re near the top of the cycle. Combined ratio fell to 77.9% [V] and net income to common was ~USD 2.5B [M], aided by the reversal of 2022 mark-to-market losses.
2024: scale year. Full-year Validus lifted GPW 32% to USD 11.7B. Underwriting income was stable at USD 1.62B despite USD 779.8M of large-loss impacts in Property (2024 Large Loss Events, chiefly Hurricanes Helene and Milton) [V]. Net investment income rose to USD 1.65B. Net income to common dropped to USD 1.8B as investment gains were smaller.
2025: record earnings despite record-level wildfire loss. The California wildfires inflicted a ~USD 1.1B net hit in Q1 2025 [V, secondary], pushing Q1 combined ratio to 128.3%. Yet the remaining quarters were exceptionally benign for catastrophe, Q3 2025 delivered record operating EPS of USD 15.62 [V], and investment gains were substantial, producing record net income to common of USD 2.65B and 26.2% BVPS growth [V].
2026: harvest phase. H1 2026 combined ratios in the low 70s reflect light catastrophe activity and favorable reserve releases in Property (USD 257.5M favorable in Q2 alone [V]), while premiums are contracting as property-cat rates fall (Guy Carpenter ROL index −16% at 1 July 2026 [V]). Management is returning excess capital via buybacks (~USD 350M per quarter) rather than chasing premium.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property gross premiums written (USD Mn) | 3,562.4 | 4,823.7 | 4,942.1 |
Casualty & Specialty gross premiums written (USD Mn) | 5,300.0 | 6,909.3 | 6,796.3 |
Total gross premiums written (USD Mn) | 8,862.4 | 11,733.1 | 11,738.4 |
Property net premiums written (USD Mn) | 2,967.3 | 3,833.6 | 4,044.0 |
Casualty & Specialty net premiums written (USD Mn) | — | 6,118.6 | 5,826.2 |
Property net premiums earned (USD Mn) | — | 3,850.4 | 3,971.7 |
Casualty & Specialty net premiums earned (USD Mn) | — | 6,245.4 | 5,929.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property underwriting income (USD Mn) | 1,439.3 | 1,647.7 | 1,533.3 |
Casualty & Specialty underwriting income (USD Mn) | 208.1 | -25.4 | -263.3 |
Total underwriting income (USD Mn) | 1,647.4 | 1,622.3 | 1,270.0 |
Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property combined ratio (%) | 53.4 | 57.2 | 61.4 |
Casualty & Specialty combined ratio (%) | 95.2 | 100.4 | 104.4 |
Group combined ratio (%) | 77.9 | 83.9 | 87.2 |
Property underwriting expense ratio (%) | 27.5 | 27.5 | 25.5 |
Casualty & Specialty underwriting expense ratio (%) | 31.9 | 33.3 | 33.7 |
Group underwriting expense ratio (%) | 30.1 | 31.1 | 30.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property GPW YoY growth (%) | — | 35.4 | 2.5 |
Casualty & Specialty GPW YoY growth (%) | — | 30.4 | -1.6 |
Property share of group GPW (%) | 40.2 | 41.1 | 42.1 |
Casualty & Specialty share of group GPW (%) | 59.8 | 58.9 | 57.9 |
Revenue by Segment (%) and Results by Segment
| Metric | Q1 2026 | Q2 2026 |
|---|---|---|
Group combined ratio (%) | 73.0 | 72.8 |
Property combined ratio (%) | 34.1 | 27.1 |
Casualty & Specialty combined ratio (%) | 100.4 | 103.3 |
Group underwriting income (USD Mn) | 588.8 | 599.1 |
Property underwriting income (USD Mn) | — | 642.7 |
Property GPW (USD Mn) | — | 1,550 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross premiums written (USD Mn) | 7,833.9 | 9,213.6 | 8,862.4 | 11,733.1 | 11,738.4 |
Net premiums earned (USD Mn) | — | — | — | 10,095.8 | 9,901.2 |
Underwriting income (USD Mn) | — | — | 1,647.4 | 1,622.3 | 1,270.0 |
Net investment income (USD Mn) | — | — | — | 1,654.3 | 1,703.5 |
Fee income (USD Mn) | — | 120 | — | — | 329 |
Net income — total incl. NCI (USD Mn) | — | — | — | 2,960.5 | 3,617.7 |
Net income available to common (USD Mn) | -73.4 | -1,096.4 | 2,525.8 | 1,835.0 | 2,647.0 |
Operating income available to common (USD Mn) | — | — | — | 2,200 | 1,859.7 |
Diluted EPS (USD) | -1.57 | -25.50 | 52.27 | 35.21 | 56.03 |
Basic EPS (USD) | -1.57 | -25.50 | 52.40 | 35.31 | 56.23 |
Operating EPS diluted (USD) | — | — | — | 42.97 | 39.10 |
Dividends per common share (USD) | 1.44 | 1.48 | 1.52 | 1.56 | 1.60 |
Margin Analysis (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Combined ratio (%) | 77.9 | 83.9 | 87.2 |
Net claims ratio — current accident year (%) | — | 61.3 | 67.7 |
Net claims ratio — calendar year (%) | — | 52.8 | 56.7 |
Underwriting expense ratio (%) | 30.1 | 31.1 | 30.5 |
Return on average common equity (%) | — | — | 26.0 |
Operating ROACE (%) | — | 23.5 | 18.0 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (USD Mn) | 33,960 | 36,553 | 49,007 | 50,708 | 53,800 |
Goodwill & intangibles (USD Mn) | 243 | 238 | 775 | 704 | 633 |
Total debt — senior notes (USD Mn) | 1,168 | 1,170 | 1,959 | 1,887 | 2,329 |
Common shareholders' equity (USD Mn) | 5,874 | 4,575 | 8,705 | 9,824 | 10,859 |
Preference shares (USD Mn) | 750 | 750 | 750 | 750 | 750 |
Total shareholders' equity attrib. to RNR (USD Mn) | 6,624 | 5,325 | 9,455 | 10,574 | 11,609 |
Total equity incl. redeemable NCI (USD Mn) | 10,178 | 9,861 | 15,556 | 17,552 | 19,211 |
Book value per common share (USD) | 137.03 | 104.65 | 165.20 | 195.77 | 247.00 |
Tangible BVPS (USD) | — | — | — | 177.18 | 230.10 |
Accumulated dividends per share (USD) | — | — | — | 28.08 | 29.68 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (USD Mn) | — | — | — | — | 3,690 |
Common share repurchases (USD Mn) | — | — | — | — | 1,600 |
Debt issued, net (USD Mn) | 0 | 0 | 741 | 0 | 889 |
Debt repaid (USD Mn) | 0 | 0 | 30 | 75 | 450 |
Margin Analysis (%) — ROACE
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
ROACE (%) | — | — | 26.0 |
ROA — net income to common ÷ avg total assets (%) | — | 3.7 | 5.1 |
Debt to capital (%) | 17.2 | 15.1 | 16.7 |
Debt to common equity (%) | 22.5 | 19.2 | 21.4 |
Dividends & Capital Returns and Per-Share Data
| Metric | Q1 2026 | Q2 2026 |
|---|---|---|
Net income available to common (USD Mn) | 284.5 | 654.2 |
Operating income available to common (USD Mn) | 590.5 | 547.8 |
Diluted EPS (USD) | 6.57 | 15.48 |
Operating EPS diluted (USD) | 13.75 | 12.92 |
Underwriting income (USD Mn) | 588.8 | 599.1 |
Fee income (USD Mn) | 94.1 | 83.0 |
Net investment income (USD Mn) | 420.5 | 432.5 |
Combined ratio (%) | 73.0 | 72.8 |
Book value per common share (USD) | 250.48 | 264.77 |
Tangible BVPS (USD) | 233.49 | — |
Annualized ROACE (%) | 10.5 | 24.0 |
Annualized operating ROACE (%) | — | 20.1 |
Share repurchases (USD Mn) | 352.5 | 350.0 |
Revenue by Region
| Class (GPW, USD Mn) | H1 2024 | H1 2025 |
|---|---|---|
Property — catastrophe (incl. reinstatements) | 2,605.7 | 3,029.3 |
Property — other property | 1,037.3 | 833.4 |
Casualty & Specialty — general casualty | 1,219.9 | 1,193.5 |
Casualty & Specialty — total | 3,773.2 | 3,713.9 |
Revenue by Region (Annual)
| Class (GPW, USD Mn) | 9M 2024 | 9M 2025 |
|---|---|---|
Property — total | 4,433.7 | 4,596.0 |
Property — other property | 1,484.0 | 1,278.3 |
Casualty & Specialty — general casualty | 1,739.5 | 1,677.4 |
Casualty & Specialty — total | 5,382.6 | 5,304.3 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Share price (late July 2026) | ~USD 329.10 (24 Jul 2026) | MarketChameleon [V, secondary] |
Share price (mid/late 2026, latest available) | ~USD 322 | Equibles [V, secondary] |
52-week range | ~USD 231.6–334.2 (closing basis) | Equibles [V, secondary] |
1-year return (to 24 Jul 2026) | +38.4% (vs. SPY +17.7%) | MarketChameleon [V, secondary] |
Market Valuation
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Market capitalization (USD Bn) | 7.93 | 9.33 | 12.77 | 12.62 |
Valuation Snapshot by Multiple
| Multiple | Value | Basis |
|---|---|---|
Price / book value | ~1.22x | USD 322 ÷ BVPS USD 264.77 (Q2 2026) |
Price / tangible book | ~1.3x | — |
P/E (trailing GAAP) | ~5.5–6x | Trailing GAAP EPS ~USD 56–60 |
P/E (FY2025 operating EPS USD 39.10) | ~8.2x | — |
EV/EBITDA, EV/Sales | Not meaningful for a reinsurer | — |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends per share (USD) | 1.44 | 1.48 | 1.52 | 1.56 | 1.60 |
Credit Ratings
| Agency | Rating | Status |
|---|---|---|
AM Best (FSR, core operating subs) | A+ (Superior) | Affirmed July 2026 [V] |
S&P (FSR, Renaissance Reinsurance) | A+ | [M] |
Moody's (IFSR) | A1 | [M] |
Debt Maturity Profile
| Maturity bucket | Amount (USD Mn) |
|---|---|
Senior notes, total | 2,329 |
Analyst Conclusions
Management guidance
No formal earnings guidance [V, secondary]. Directional messages from the Q2 2026 call: strategy unchanged; market "changing" not "soft"; rate adequacy broadly intact; caution in general liability; continued buybacks; confidence in the balance of 2026 [V].
Consensus expectations
Directionally, analysts expect lower premium volumes in 2026–2027, continued strong property margins absent large catastrophes, and moderating ROE from ~20% toward mid-teens as pricing softens.
Bull case
-
Compounding book value: BVPS +24.8% YoY to June 2026 [V], with buybacks at ~1.2x book adding accretion.
-
Three profit engines: NII (~USD 1.7B) and fees (~USD 330M) provide ~USD 2B of relatively stable pre-tax earnings before underwriting [V].
-
Underwriting discipline: low-70s combined ratios in H1 2026 [V] with pricing still above pre-2023 levels.
Bear case
-
Cycle turn: ROL −16% at mid-2026 [V]; premiums falling double digits in Q2 2026 [V].
-
Casualty drag: C&S combined ratio above 100% for two consecutive years plus Q2 2026 [V].
-
Event risk: a single mega-catastrophe could cost more than a year's earnings; 2025 wildfires show the scale (~USD 1.1B).
Key catalysts and monitorables (next 12 months)
-
Q3 2026 results on 27 October 2026 (catastrophe losses from the 2026 Atlantic hurricane season).
-
1 January 2027 renewal pricing and RenRe's share retention.
-
CFO transition to Matthew Neuber on 1 January 2027.
-
Casualty reserve development and any reserve strengthening.
-
Pace of buybacks versus the USD 750M authorization.
-
Bermuda tax credit realization; NII trajectory as rates move.
Analyst verdict
RenaissanceRe enters late 2026 at the peak of its earnings power. After the catastrophe-heavy, capital-depleting years of 2021–2022, management executed a near-ideal sequence: raising prices aggressively at the hard-market inflection of 2023, buying Validus Re at the top of the cycle, and expanding its third-party capital franchise so that fee income nearly tripled. The results speak for themselves: record FY2025 net income to common of USD 2.65 billion, BVPS up 26.2% in 2025 and a further 24.8% in the twelve months to June 2026, and H1 2026 combined ratios around 73%.
The question for investors is no longer whether RenaissanceRe is a superior underwriter — the property segment's sub-62% combined ratio even in a record-wildfire year answers that — but how much of the current earnings rate is cyclical. Property-catastrophe pricing fell 16% at the July 2026 renewal, RenRe's catastrophe premiums fell 13.9% in Q2 2026, and the Casualty and Specialty segment continues to run above a 100% combined ratio. Management is responding rationally: shrinking where pricing erodes, buying more casualty retrocession, and returning roughly USD 350 million per quarter through buybacks.
At ~1.2x book value and ~8x FY2025 operating earnings, the stock prices in a meaningful normalization of returns. That valuation appears reasonable for a franchise that has historically compounded book value through cycles, but it offers less margin of safety than in 2023–2024. The investment case now rests on capital discipline, the durability of fee and investment income, and the absence of a mega-catastrophe. Near-term, the Q3 2026 print (hurricane season losses) and the 1 January 2027 renewal will set the tone. Overall verdict: a high-quality, well-capitalized cycle-manager whose best earnings growth is likely behind it, but whose book-value compounding should remain above peers.
End of dossier.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / prior roles | Status |
|---|---|---|---|
Kevin J. O'Donnell | President & Chief Executive Officer; Director | CEO since July 2013; previously Global Chief Underwriting Officer; joined RenaissanceRe in 1996 [M] | Title [V] |
Robert ("Bob") Qutub | EVP & Chief Financial Officer | CFO since 2016 (employment agreement July 2016); retiring 31 Dec 2026; will serve as strategic advisor for 12 months; previously CFO at MSCI and senior roles at Bank of America [M for prior roles] | [V] |
Matthew Neuber | Senior Financial Officer & Corporate Treasurer; CFO-designate (effective 1 Jan 2027) | Joined 2014; Corporate Treasurer since 2019; oversees capital management, planning and forecasting; prior private equity and asset management; began career at Keefe, Bruyette & Woods covering insurance | [V] |
Ross Curtis | EVP & Chief Portfolio Officer | Retiring 31 Dec 2026; strategic advisor for six months; responsibilities pass to David Marra | [V] |
David Marra | Group Chief Underwriting Officer | Will assume oversight of portfolio function in 2027; credited by CEO with expanding the book organically and via Validus | [V] |
Shannon Lowry Bender | EVP, Group General Counsel & Corporate Secretary | [M] | — |
Sean Brosnan | Chief Investment Officer | [M] | — |
Keith McCue | SVP, Finance & Investor Relations | IR contact | [V] |
Hayden Kenny | SVP, Investor Relations & Communications | Media contact (2025) | [V] |
Board of Directors
| Director | Role | Notes |
|---|---|---|
Henry Klehm III | Non-Executive Chair (from May 2026) | Existing director prior to appointment |
James L. Gibbons | Independent director; Audit Committee member | Former Non-Executive Chair |
Stephen C. Hooley | Independent director (elected May 2026) | Succeeded David C. Bushnell |
Kevin J. O'Donnell | Executive director (CEO) | — |
David C. Bushnell | Retired May 2026 after 18 years | — |
Other independent directors | Includes (as of recent proxies) Brian G. J. Gray, Duncan P. Hennes, Shyam Gidumal, Valerie Rahmani, Carol P. Sanders, Cynthia Trudell and others | — |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
6 May 2026 | Henry Klehm III appointed Non-Executive Chair; Stephen Hooley joins; David Bushnell retires | Board refresh [V] |
11–14 May 2026 | CFO Qutub and CPO Curtis notify board of retirement effective 31 Dec 2026; Neuber named CFO | Planned succession [V] |
1 Jan 2027 (scheduled) | Neuber becomes CFO; Marra assumes portfolio oversight | [V] |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Positioning vs. RenaissanceRe |
|---|---|---|
Munich Re | Property cat, casualty, specialty | Global #1 reinsurer; far larger, diversified with primary (ERGO) and life |
Swiss Re | Property cat, casualty, specialty | Global #2; diversified, large life & health |
Hannover Re | Property cat, casualty, specialty | Global #3; cost leader |
SCOR | Property, casualty, specialty | Global top-5; recent underperformance |
Berkshire Hathaway Reinsurance Group (incl. Gen Re) | Property cat, casualty | Massive capital base; opportunistic cat writer |
Lloyd's market (syndicates) | Specialty, property | Fragmented competitor and partner |
Everest Group | Property cat, casualty | Bermuda/U.S. peer; casualty reserve issues in 2024–2025 |
Arch Capital Group | Property cat, mortgage, specialty | Diversified Bermuda peer; strong mortgage franchise |
PartnerRe (Covéa) | Property, casualty, specialty | Privately held Bermuda peer |
Hamilton Insurance Group | Property cat, specialty | Smaller Bermuda peer |
Fidelis Insurance Holdings | Property cat, specialty | Bermuda specialty peer |
ILS funds (e.g., Nephila, Fermat, Elementum) and cat bond market | Property cat | Alternative capital; also RenRe competes via Medici/AlphaCat |
Competitor Detail
| Metric | RenaissanceRe |
|---|---|
FY2025 GPW (USD Bn) | 11.7 |
FY2025 combined ratio (%) | 87.2 |
FY2025 BVPS growth (%) | 26.2 |



